Sheela Mohan-Peterson was Appointed as General Counsel at OncoSec Medical

Date of management change: September 17, 2014 

What Happened?

San Diego, CA-based OncoSec Medical has Appointed Sheela Mohan-Peterson as General Counsel

 

About the Company

OncoSec Medical Inc. is a biopharmaceutical company developing its ImmunoPulse immunotherapy to treat solid tumors. OncoSec Medical’s core technology leverages a proprietary electroporation platform to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-modulating agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response without the systemic toxicities associated with other treatments. OncoSec’s clinical programs currently include three Phase 2 trials targeting metastatic melanoma Merkel cell carcinoma and cutaneous T-cell lymphoma conducted in collaboration with several prominent academic medical centers. As the company continues to evaluate ImmunoPulse in these indications it is also investigating additional indications and combination therapeutic approaches.  

 

About the Person

Sheela Mohan-Peterson has spent more than 27 years working in the pharmaceutical and biotech industries most recently as a Senior Patent Counsel with Merck & Co. Inc. She received her bachelor’s degree in biology from Washington University in St. Louis and her master’s degree in molecular biology from Rutgers University. Ms. Mohan-Peterson began her career in 1986 as a scientist in the Tumor Biology department of Schering-Plough Research Institute in Bloomfield New Jersey. In 1991 she transferred to the Human Immunology department at DNAX Research Institute a subsidiary of Schering-Plough located in Palo Alto California. After graduating from law school in 1997 she began her career as a patent attorney at Incyte Genomics in Palo Alto and then as a patent counsel at Roche Bioscience also in Palo Alto. In 2000 she returned to DNAX as a senior patent counsel and remained there for several years after a merger with Merck.  

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Gerst Christopher, Brom Jeffrey, Vonakenel James, Miller Kelly, Verteramo Jared, Park April, Wang Austin, Sharma Rajesh, Cinque John, George Robert, Patton Phillip

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.